Memberships

MetrioPharm

MetrioPharm Memberships

News

MetrioPharm AG Publishes Annual Report for 2018 - 2019-May-16

Financing round D for 20 CHF was closed, Phase II clinical trial successfully initiated, Focus of the report: InflammAging.

» more

Investor Relations

MetrioPharm Investor Relations News QI 2019 - 2019-Mar-29

Topics: J.P. Morgen Healthcare Conference, San Francisco, BIO CEO & Investor Conference, New York, European Life Science CEO Forum, Zurich, Bio-Europe Spring, Vienna, Corporate Calendar of MetrioPharm AG

» more

Navigation

Home
About us
Technology
Pipeline
Investors
Press
Contact
Blog

Social

  

Newsletter

Subscribe to our press releases with the
MetrioPharm PR newsletter

Investors can subscribe to our quaterly corporate information with the
MetrioPharm IR newsletter

Switzerland (HQ)

MetrioPharm AG

Bleicherweg 45
8002 Zurich

Phone: +41 (44) 515 21 97

Germany (R&D)

MetrioPharm Deutschland GmbH

Am Borsigturm 100
13507 Berlin

Phone: +49 (0)30 – 3384 395 02

Imprint
Privacy policy
Sitemap